1. Fang G, Chen B, Fu W, et al. Strategies for endovascler treatment ofcomplicated splenic artery aneurysms. J Vasc Surg. 2018;68:787-794.
2. Pararas N, Rajendiran S, Taha I, Powar RR, Holguera C, Tadros E.Spontaneous rupture of a huge splenic artery aneurysm: a case report. AmJ Case Rep. 2020;21:e919956.
3. Kitamura H, Nakayama K, Kitano T, Ozaki N, Nagaoka S. Removal ofa splenic artery with a large aneurysm adhered to the pancreas withoutpancreatectomy: report of a case. Surg Taday. 2002;32(8):747-749.
4. Kehagias DT, Tzalonikos MT, Moulopoulos LA, Gouliamos AD, MourikisDA, Vlahos LJ. MRI of a giant splenic artery aneurysm. Br J Radiol.1998;71:444-446.
5. Abdulrahman A, Shabkah A, Hassanain M, Aljiffry M. Rupturedspontaneous splenic artery aneurysm: a case report and review of theliterature. Int J Surg Case Rep. 2014;5(10):754.
6. Liu CF, Kung CT, Liu BM, Ng SH, Huang CC, Ko SF. Splenic arteryaneurysms encountered in the ED: 10 years’ experience. Am J Emerg Med.2007;25:430-436.
7. Sadat U, Dar O, Walsh S, Varty K. Splenic artery aneurysms in pregnancy-asystematic review. Int J Surg. 2008;6:261-5.
8. Abbas MA, Stone WM, Fowl RJ, et al. Splenic artery aneurysms: twodecades experience at Mayo Clinic. Ann Vasc Surg. 2002;16(4):442-449.
9. Nincheri Kunz M, Pantalone D, Borri A, et al. Management of the splenicartery aneurysms. Two case reports and review of the literature. MinervaChir. 2003;58(2):247-256.
10. Muscari F, Bossavy JP, Chaufour X, Ghouti L, Barret A. Laparoscopicexclusion of a splenic artery aneurysma case report. Vasc EndovascularSurg. 2003;37:297-300
11. Arca MJ, Gagner M, Heniford BT, Sullivan TM, Beven EG. Splenic arteryaneurysms: methods of laparoscopic repair. J Vasc Surg. 1999;30:184-188.
12. Nadkarni GN, Lala A, Bagiella E, et al. Anticoagulation, bleeding,mortality, and pathology in hospitalized patients with COVID-19. J AmColl Cardiol. 2020; 76(16):1815-1826.
13. Moores L, Tritschler T, Brosnahan S, et al. Prevention, diagnosis, andtreatment of VTE in patients with coronavirus disease. 2019: CHESTGuideline and Expert Panel Report. Chest. 2020;158(3):1143-1163.
14. Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and StandardizationCommittee communication: clinical guidance on the diagnosis,prevention, and treatment of venous thromboembolism in hospitalizedpatients with COVID-19. J Thromb Haemost. 2020:1859-1865.
15. Billet HH, Reyes-Gil M, Szymanski J, et al. Anticoagulation in COVID-19:effect of enoxaparin, heparin, and apixaban on mortality. Thromb Haemost.2020;120:1691-1699.
16. Botezatu C, Petrutescu M, Forminte M, Mastalier BS. Severe bleedingcomplications resulting in death following anticoagulant treatment inCOVID-19 surgical patients. Chirurgia. 2020;115(6):798-806.
17. Mattioli M, Benfaremo D, Mancini M, et al. Safety of intermediatedose of low molecular weight heparin in COVID-19 patients. J ThrombThrombolysis 2020;51:286-292. doi: 10.1007/s11239-020-02243-z.
18. Taylor S, Zvolensky MJ, Cox BJ, et al. Robust dimensions of anxietysensitivity: development and initial validation of the anxiety sensitivityindex-3. Psychological Assessment. 2007;19(2):176-188.
19. Cordova AC, Sumpio BE. Visceral artery aneurysms andpseudoaneurysms—should they all be managed by endovasculartechniques? Ann Vasc Dis. 2013;6(4):687-693.